Suchergebnisse - "Brueckl, Wolfgang M"

PubPharm (68)

1

Checkpoint Inhibitor Monotherapy in Potentially Trial-Eligible or Trial-Ineligible Patients With Metastatic NSCLC in the German Prospective CRISP Registry Real-World Cohort (AIO-TRK-0315)

enthalten in: JTO clinical and research reports | 2024

von Griesinger, F. | Sebastian, M. | Brueckl, W. | +117

2

Combination of the platelet-to-lymphocyte ratio and fibrinogen may predict 5-year overall survival of patient in non-small cell lung cancer treated with surgery

enthalten in: Journal of thoracic disease | 2023

von Luo, Y. | Lin, K. | Zhang, M. | +6

3

Fluctuation of Acquired Resistance Mutations and Re-Challenge with EGFR TKI in Metastatic NSCLC : A Case Report

enthalten in: Current oncology (Toronto, Ont.) | 2023

von Falk, M. | Schatz, S. | Reich, F. | +5

4

Dynamic change of CD8+ T cell : immunotherapy fate tell?

enthalten in: Translational lung cancer research | 2023

von Brueckl, W.

CommentOn: Transl Lung Cancer Res. 2022 Nov;11(11):2192-2207. - PMID 36519023

5

Comparative efficacy and safety of multitarget angiogenesis inhibitor combined with immune checkpoint inhibitor and nivolumab monotherapy as second-line or beyond for advanced lung adenocarcinoma in driver-negative patients : a retrospective comparative cohort study

enthalten in: Translational lung cancer research | 2023

von Yu, L. | Xu, J. | Qiao, R. | +3

6

Response of an HER2-Mutated NSCLC Patient to Trastuzumab Deruxtecan and Monitoring of Plasma ctDNA Levels by Liquid Biopsy

enthalten in: Current oncology (Toronto, Ont.) | 2023

von Falk, M. | Willing, E. | Schmidt, S. | +5

7

Older patients with EGFR mutation-positive non-small cell lung cancer treated with afatinib in clinical practice : A subset analysis of the non-interventional GIDEON study

enthalten in: Journal of geriatric oncology | 2023

von Brueckl, W. | Reck, M. | Schäfer, H. | +9

8

The impact of TP53 co-mutations and immunologic microenvironment on outcome of lung cancer with EGFR exon 20 insertions

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Christopoulos, P. | Kluck, K. | Kirchner, M. | +34

9

The impact of TP53 co-mutations and immunologic microenvironment on outcome of lung cancer with EGFR exon 20 insertions

enthalten in: European journal of cancer | 20 May 2022

von Christopoulos, P. | Kluck, K. | Kirchner, M. | +34

10

A nomogram to predict the recurrence-free survival and analyze the utility of chemotherapy in stage IB non-small cell lung cancer

enthalten in: Translational lung cancer research | 2022

von Zhang, Z. | Xie, S. | Cai, W. | +12

1
2
3
4
5
6
7
Nächster »
[7]